Levi Strauss & Co. SEC Filings

Margaret E. Haas, Board Chair of Levi Strauss & Co. (LEVI), reported transactions on 10/01/2025. She converted 50,000 shares of Class B common stock into 50,000 shares of Class A common stock and, pursuant to a Rule 10b5-1 plan adopted on 4/14/2025, sold 50,000 Class A shares for a weighted average price of $24.1381 per share, with sale prices ranging from $24.00 to $24.41. After the reported sale, the specific converted holding was reduced to 0 shares held directly by the reporting capacity; other Class A and Class B shares are reported as held indirectly by trusts and charitable entities for which Ms. Haas disclaims beneficial ownership.

Peter E. Haas Jr. Family Fund, a reporting person and director of Levi Strauss & Co. (LEVI), reported transactions dated 10/01/2025. The filing shows the conversion of 150,000 Class B shares into 150,000 Class A shares and the sale of those 150,000 Class A shares under a prearranged Rule 10b5-1 plan adopted on April 14, 2025 at a weighted average price of $24.1855 per share, with individual sale prices ranging from $24.00 to $24.41. After the reported transactions the reporting entity holds 0 Class A shares beneficially. The form is signed by an attorney-in-fact on behalf of the reporting fund on 10/03/2025.

LEVI STRAUSS & CO. notice reports a proposed Rule 144 sale of 350,000 common shares through The Charles Schwab Corporation, with an aggregate market value of $9,600,000.00. The shares are listed on the NYSE and the filer cites an approximate sale date of 10/01/2025.

The filing shows these shares were acquired by inheritance on 02/14/2007 from Peter E. Haas Sr., and no securities of the issuer were reported sold by the filer in the past three months. The notice includes the standard representation that the seller is not aware of undisclosed material adverse information about the issuer.

LEVI STRAUSS & CO (LEVI) reported a Form 144 notice for the proposed sale of 4,395 Class A shares through Fidelity Brokerage Services on the NYSE with an aggregate market value of $105,480. The shares were acquired mainly through restricted stock vesting in 2024 as compensation, in tranches of 520, 2,962, 720 and 193 shares between January and July 2024. The filer represents they are unaware of any undisclosed material adverse information and indicates prior sales by the same person totaling 3,629 shares on 07/11/2025 that generated gross proceeds of $79,838. The notice lists the broker, planned approximate sale date of 10/01/2025, and confirms the holdings outstanding at 107,206,840 shares.

Levi Strauss & Co. (LEVI) filed an initial Form 3 disclosing that Timothy Joseph Davis, who serves as SVP, Global Controller and an officer/director, reported a qualifying event dated 08/11/2025. The filing states no securities are beneficially owned by the reporting person as of the event date. The form was signed by an attorney-in-fact on 08/20/2025, and includes an Exhibit 24 power of attorney.

Margaret E. Haas, a director of Levi Strauss & Co., reported conversions of Class B common stock into Class A on 04/15/2025 and 08/11/2025, converting 133,443 and 209,450 shares respectively. Each Class B share is convertible into one share of Class A and has no expiration.

The filing also shows private sales of 16,273 and 25,723 Class B shares at prices of $14.72 and $20.07. Reported direct beneficial ownership following the April transactions was 13,610,828 shares and following the August transactions was 13,375,655; reported indirect holdings were 21,109,593 and 21,319,043. Footnotes state many shares are held in trusts and charitable entities and that Ms. Haas disclaims beneficial ownership of certain shares held for others.

Capital Research Global Investors filed a Schedule 13G reporting its position in Levi Strauss & Co. common stock as a beneficial owner of 0 shares, representing 0.0% of the 104,585,522 shares the filing states are outstanding. The filing identifies CRGI as an investment adviser division of Capital Research and Management Company and related investment management entities and states that, collectively under the name Capital Research Global Investors, they are deemed to beneficially own 0 shares.

The filing shows 0 sole and 0 shared voting powers and 0 sole and 0 shared dispositive powers, and includes a certification that the securities (if any) are held in the ordinary course of business and not to influence control of the issuer.